These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 31759623)
21. Long term survival with stereotactic ablative radiotherapy (SABR) versus thoracoscopic sublobar lung resection in elderly people: national population based study with propensity matched comparative analysis. Paul S; Lee PC; Mao J; Isaacs AJ; Sedrakyan A BMJ; 2016 Jul; 354():i3570. PubMed ID: 27400862 [TBL] [Abstract][Full Text] [Related]
22. Association of Survival With Adjuvant Chemotherapy Among Patients With Early-Stage Non-Small Cell Lung Cancer With vs Without High-Risk Clinicopathologic Features. Pathak R; Goldberg SB; Canavan M; Herrin J; Hoag JR; Salazar MC; Papageorge M; Ermer T; Boffa DJ JAMA Oncol; 2020 Nov; 6(11):1741-1750. PubMed ID: 32940636 [TBL] [Abstract][Full Text] [Related]
23. A pilot study of adjuvant chemotherapy with irinotecan and cisplatin for completely resected high-grade pulmonary neuroendocrine carcinoma (large cell neuroendocrine carcinoma and small cell lung cancer). Kenmotsu H; Niho S; Ito T; Ishikawa Y; Noguchi M; Tada H; Sekine I; Watanabe S; Yoshimura M; Yamamoto N; Oshita F; Kubota K; Nagai K Lung Cancer; 2014 Jun; 84(3):254-8. PubMed ID: 24679951 [TBL] [Abstract][Full Text] [Related]
25. Large cell neuroendocrine carcinoma: an aggressive form of non-small cell lung cancer. Battafarano RJ; Fernandez FG; Ritter J; Meyers BF; Guthrie TJ; Cooper JD; Patterson GA J Thorac Cardiovasc Surg; 2005 Jul; 130(1):166-72. PubMed ID: 15999058 [TBL] [Abstract][Full Text] [Related]
26. Adjuvant chemotherapy for elderly patients with non-small-cell lung cancer. Yamanashi K; Okumura N; Yamamoto Y; Takahashi A; Nakashima T; Matsuoka T; Kameyama K Asian Cardiovasc Thorac Ann; 2017 Jun; 25(5):371-377. PubMed ID: 28592139 [TBL] [Abstract][Full Text] [Related]
27. Distinct clinicopathologic features, genomic characteristics and survival of central and peripheral pulmonary large cell neuroendocrine carcinoma: From different origin cells? Zhou F; Hou L; Ding T; Song Q; Chen X; Su C; Li W; Gao G; Ren S; Wu F; Fan J; Wu C; Zhang J; Zhou C Lung Cancer; 2018 Feb; 116():30-37. PubMed ID: 29413048 [TBL] [Abstract][Full Text] [Related]
28. Outcomes of lobar and sublobar resections for non-small-cell lung cancer: a single-center experience. Kim D; Ferraris VA; Davenport D; Saha S South Med J; 2015 Apr; 108(4):230-4. PubMed ID: 25871994 [TBL] [Abstract][Full Text] [Related]
29. The efficacy of chemotherapy and operation in patients with colorectal neuroendocrine carcinoma. Wu Z; Yu D; Zhao S; Gao P; Song Y; Sun Y; Chen X; Wang Z J Surg Res; 2018 May; 225():54-67. PubMed ID: 29605035 [TBL] [Abstract][Full Text] [Related]
30. Survival outcomes and incidence of brain recurrence in high-grade neuroendocrine carcinomas of the lung: Implications for clinical practice. Metro G; Ricciuti B; Chiari R; Baretti M; Falcinelli L; Giannarelli D; Sidoni A; Mountzios G; Crinò L; Bellezza G; Rebonato A; Ferolla P; Toschi L Lung Cancer; 2016 May; 95():82-7. PubMed ID: 27040856 [TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical studies of pulmonary large cell neuroendocrine carcinoma: a possible association between staining patterns with neuroendocrine markers and tumor response to chemotherapy. Tanaka Y; Ogawa H; Uchino K; Ohbayashi C; Maniwa Y; Nishio W; Nakao A; Yoshimura M J Thorac Cardiovasc Surg; 2013 Mar; 145(3):839-46. PubMed ID: 22498090 [TBL] [Abstract][Full Text] [Related]
32. The clinicopathological features and treatment modalities associated with survival of neuroendocrine cervical carcinoma in a Chinese population. Zhang X; Lv Z; Lou H BMC Cancer; 2019 Jan; 19(1):22. PubMed ID: 30616631 [TBL] [Abstract][Full Text] [Related]
33. Neoadjuvant and adjuvant chemotherapy in resected pulmonary large cell neuroendocrine carcinomas: a single institution experience. Sarkaria IS; Iyoda A; Roh MS; Sica G; Kuk D; Sima CS; Pietanza MC; Park BJ; Travis WD; Rusch VW Ann Thorac Surg; 2011 Oct; 92(4):1180-6; discussion 1186-7. PubMed ID: 21867986 [TBL] [Abstract][Full Text] [Related]
34. Large cell neuroendocrine carcinoma of the lung: a 10-year clinicopathologic retrospective study. Paci M; Cavazza A; Annessi V; Putrino I; Ferrari G; De Franco S; Sgarbi G Ann Thorac Surg; 2004 Apr; 77(4):1163-7. PubMed ID: 15063227 [TBL] [Abstract][Full Text] [Related]
35. Clinical management of atypical carcinoid and large-cell neuroendocrine carcinoma: a multicentre study on behalf of the European Association of Thoracic Surgeons (ESTS) Neuroendocrine Tumours of the Lung Working Group†. Filosso PL; Rena O; Guerrera F; Moreno Casado P; Sagan D; Raveglia F; Brunelli A; Welter S; Gust L; Pompili C; Casadio C; Bora G; Alvarez A; Zaluska W; Baisi A; Roesel C; Thomas PA; Eur J Cardiothorac Surg; 2015 Jul; 48(1):55-64. PubMed ID: 25406425 [TBL] [Abstract][Full Text] [Related]
36. Role of Adjuvant Therapy for Node-Negative Lung Cancer Invading the Chest Wall. Gao SJ; Corso CD; Blasberg JD; Detterbeck FC; Boffa DJ; Decker RH; Kim AW Clin Lung Cancer; 2017 Mar; 18(2):169-177.e4. PubMed ID: 27890561 [TBL] [Abstract][Full Text] [Related]
37. Multimodality therapy for locally advanced thymomas: A propensity score-matched cohort study from the European Society of Thoracic Surgeons Database. Leuzzi G; Rocco G; Ruffini E; Sperduti I; Detterbeck F; Weder W; Venuta F; Van Raemdonck D; Thomas P; Facciolo F; J Thorac Cardiovasc Surg; 2016 Jan; 151(1):47-57.e1. PubMed ID: 26403869 [TBL] [Abstract][Full Text] [Related]
38. A national analysis of wedge resection versus stereotactic body radiation therapy for stage IA non-small cell lung cancer. Yerokun BA; Yang CJ; Gulack BC; Li X; Mulvihill MS; Gu L; Wang X; Harpole DH; D'Amico TA; Berry MF; Hartwig MG J Thorac Cardiovasc Surg; 2017 Aug; 154(2):675-686.e4. PubMed ID: 28461054 [TBL] [Abstract][Full Text] [Related]